Wade Lovelace

694 total citations · 1 hit paper
6 papers, 397 citations indexed

About

Wade Lovelace is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Wade Lovelace has authored 6 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Hematology and 2 papers in Immunology. Recurrent topics in Wade Lovelace's work include Hematopoietic Stem Cell Transplantation (3 papers), Neutropenia and Cancer Infections (2 papers) and CAR-T cell therapy research (2 papers). Wade Lovelace is often cited by papers focused on Hematopoietic Stem Cell Transplantation (3 papers), Neutropenia and Cancer Infections (2 papers) and CAR-T cell therapy research (2 papers). Wade Lovelace collaborates with scholars based in United States. Wade Lovelace's co-authors include Shahbaz A. Malik, H M Lazarus, Ian W. Flinn, Julie Vose, Erin E. Karski, Surbhi Sidana, David P. Schenkein, James Hackett, Jeffrey Matous and Olalekan O. Oluwole and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Wade Lovelace

6 papers receiving 384 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results

2023 168 citations Sham Mailankody, Jeffrey Matous et al. Nature Medicine profile →

Peers

Wade Lovelace

ONCOL

HEMAT

GENET

MB

IMMUN

Salyka Sengsayadeth United States

Alberto Mussetti Spain

Evandro D. Bezerra United States

Oliver Van Oekelen United States

Fiona He United States

Noa G. Holtzman United States

Qingsong Yin China

LaQuisa Hill United States

Marta García‐Recio Spain

Joseph Maakaron United States

Salyka Sengsayadeth United States

Wade Lovelace

257 ×0.7

ONCOL

256 ×1.9

HEMAT

50 ×0.4

GENET

148 ×1.3

MB

140 ×2.2

IMMUN

Citations per year, relative to Wade Lovelace Wade Lovelace (= 1×) peers Salyka Sengsayadeth

Countries citing papers authored by Wade Lovelace

Since Specialization

Citations

This map shows the geographic impact of Wade Lovelace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wade Lovelace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wade Lovelace more than expected).

Fields of papers citing papers by Wade Lovelace

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wade Lovelace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wade Lovelace. The network helps show where Wade Lovelace may publish in the future.

Co-authorship network of co-authors of Wade Lovelace

This figure shows the co-authorship network connecting the top 25 collaborators of Wade Lovelace. A scholar is included among the top collaborators of Wade Lovelace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wade Lovelace. Wade Lovelace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Mailankody, Sham, Jeffrey Matous, Saurabh Chhabra, et al.. (2023). Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results. Nature Medicine. 29(2). 422–429. 168 indexed citations breakdown →

2.

Mailankody, Sham, Jeffrey Matous, Michaela Liedtke, et al.. (2020). Universal: An Allogeneic First-in-Human Study of the Anti-Bcma ALLO-715 and the Anti-CD52 ALLO-647 in Relapsed/Refractory Multiple Myeloma. Blood. 136(Supplement 1). 24–25. 57 indexed citations

3.

Stiff, Patrick J., William Bensinger, Muneer H. Abidi, et al.. (2009). Clinical and Ultrasonic Evaluation of Spleen Size during Peripheral Blood Progenitor Cell Mobilization by Filgrastim: Results of an Open-Label Trial in Normal Donors. Biology of Blood and Marrow Transplantation. 15(7). 827–834. 18 indexed citations

4.

Stiff, Patrick J., William Bensinger, Muneer H. Abidi, et al.. (2007). Clinical and Radiographic Evaluation of Spleen Size during Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim: Results of an Open-Label Trial in Normal Donors.. Blood. 110(11). 477–477. 1 indexed citations

5.

Vose, Julie, Michael Crump, H M Lazarus, et al.. (2003). Randomized, Multicenter, Open-Label Study of Pegfilgrastim Compared With Daily Filgrastim After Chemotherapy for Lymphoma. Journal of Clinical Oncology. 21(3). 514–519. 152 indexed citations

6.

Lovelace, Wade, et al.. (1963). Barium enema reduction of gallstone ileus. The American Journal of Surgery. 106(4). 592–595. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact